Group 1 - The second largest shareholder of Medike (688079), Hong Kong Fengsheng Jiamei (International) Investment Co., Ltd., has announced a plan to reduce its stake by up to 3% [1][3] - The planned reduction corresponds to a market value of approximately 148 million yuan based on the closing price prior to the announcement [3][4] - Medike's stock price has seen a significant increase of 55.39% from April 9 to August 18, while the overall market rose by 18.52% during the same period [3][4] Group 2 - Since its listing in 2021, Medike has faced declining annual net profits, with a notable loss in 2023 [1][5] - The company reported a net profit of approximately -159.92 million yuan in the first quarter of 2025, although this represented a reduction in losses compared to the previous year [5][6] - Medike is actively pursuing asset acquisitions to bolster its position, having completed the acquisition of 100% stakes in Haishuo Li Optoelectronics Technology (Suzhou) Co., Ltd. and INNOWAVE VIETNAM CO., LTD. [6]